Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
100% of patients in the REVEAL-1 Cohort maintained at least 5% of GLP-1-induced weight loss through one year: This 5% threshold is the responder definition used as the second co-primary endpoint in the REMAIN-1 Pivotal Cohort, which evaluates a responder rate among the Revita treated participants at one year to assess the durability of the Revita procedure for weight maintenance after GLP-1 discontinuation
it reflects your body's natural response to the absence of GLP-1 mimicry
Nutrition and lifestyle coaching
The primary role of Semaglutide is is to help patients shed weight
It may help the body lose fat by reducing appetite, improving fullness, supporting blood sugar control, and making it easier to maintain a calorie deficit
US$ 22.83
US$ 26.32
US$ 24.08
